[DPHARMA] QoQ Annualized Quarter Result on 31-Dec-2021 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
15-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Dec-2021 [#4]
Profit Trend
QoQ- -1.41%
YoY- 12.07%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 726,342 735,366 743,764 639,175 658,308 643,786 665,816 5.96%
PBT 92,672 96,238 106,584 82,983 87,808 86,746 92,704 -0.02%
Tax -22,070 -23,034 -25,420 -17,300 -21,185 -20,738 -22,248 -0.53%
NP 70,601 73,204 81,164 65,683 66,622 66,008 70,456 0.13%
-
NP to SH 70,601 73,204 81,164 65,683 66,622 66,008 70,456 0.13%
-
Tax Rate 23.82% 23.93% 23.85% 20.85% 24.13% 23.91% 24.00% -
Total Cost 655,741 662,162 662,600 573,492 591,685 577,778 595,360 6.64%
-
Net Worth 647,522 634,375 621,987 621,564 612,147 614,350 635,424 1.26%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div 6,348 9,468 - 21,660 6,278 7,061 - -
Div Payout % 8.99% 12.93% - 32.98% 9.42% 10.70% - -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 647,522 634,375 621,987 621,564 612,147 614,350 635,424 1.26%
NOSH 952,239 952,239 941,765 941,765 941,765 706,330 706,026 22.05%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 9.72% 9.95% 10.91% 10.28% 10.12% 10.25% 10.58% -
ROE 10.90% 11.54% 13.05% 10.57% 10.88% 10.74% 11.09% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 76.28 77.67 80.12 67.87 69.90 91.17 94.30 -13.17%
EPS 7.45 7.76 8.76 6.98 7.08 9.34 9.96 -17.58%
DPS 0.67 1.00 0.00 2.30 0.67 1.00 0.00 -
NAPS 0.68 0.67 0.67 0.66 0.65 0.87 0.90 -17.03%
Adjusted Per Share Value based on latest NOSH - 941,765
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 75.45 76.39 77.26 66.40 68.38 66.88 69.16 5.96%
EPS 7.33 7.60 8.43 6.82 6.92 6.86 7.32 0.09%
DPS 0.66 0.98 0.00 2.25 0.65 0.73 0.00 -
NAPS 0.6726 0.659 0.6461 0.6457 0.6359 0.6382 0.6601 1.25%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 1.30 1.20 1.49 1.68 1.81 3.03 2.75 -
P/RPS 1.70 1.55 1.86 2.48 2.59 3.32 2.92 -30.25%
P/EPS 17.53 15.52 17.04 24.09 25.59 32.41 27.56 -26.01%
EY 5.70 6.44 5.87 4.15 3.91 3.09 3.63 35.05%
DY 0.51 0.83 0.00 1.37 0.37 0.33 0.00 -
P/NAPS 1.91 1.79 2.22 2.55 2.78 3.48 3.06 -26.94%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 09/11/22 16/08/22 17/05/22 15/02/22 18/11/21 17/08/21 03/05/21 -
Price 1.39 1.34 1.51 1.60 1.62 2.49 2.93 -
P/RPS 1.82 1.73 1.88 2.36 2.32 2.73 3.11 -30.01%
P/EPS 18.75 17.33 17.27 22.94 22.90 26.64 29.36 -25.82%
EY 5.33 5.77 5.79 4.36 4.37 3.75 3.41 34.64%
DY 0.48 0.75 0.00 1.44 0.41 0.40 0.00 -
P/NAPS 2.04 2.00 2.25 2.42 2.49 2.86 3.26 -26.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment